Purple Biotech annual operating margin
2017
2018
2019
2020
Purple Biotech Operating Margin Growth & History (PPBT)
Purple Biotech's operating margin was −1,261.20% for fiscal 2020.
View full Purple Biotech company overviewPurple Biotech annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | −1,261.20% | −545.60 pp |
| 2019 | 2019-12-31 | −715.60% | +67.00 pp |
| 2018 | 2018-12-31 | −782.60% | +11183.40 pp |
| 2017 | 2017-12-31 | −11,966.00% | — |
Purple Biotech quarterly operating margin
No reported data
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Purple Biotech operating margin trends
Across the available reported history, Purple Biotech's operating margin decreased from −715.60% to −1,261.20%, a change of −545.60 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Purple Biotech filings at SEC.gov ↗